养生保健1号方干预老年慢性疲劳综合征的临床研究  被引量:3

Clinical Study of Yangsheng Baojian 1 Formula in Treatment of Chronic Fatigue Syndrome in Elderly Patients

在线阅读下载全文

作  者:钱妍[1] 吴整军[1] 仝战旗[1] 陈利平[1] 段冬梅[1] 臧倩[1] 

机构地区:[1]解放军总医院,北京100853

出  处:《中华中医药学刊》2014年第11期2573-2575,共3页Chinese Archives of Traditional Chinese Medicine

基  金:军队"十二五"重点项目(BWS11J031)

摘  要:目的:评价养生保健1号方对老年慢性疲劳综合征的治疗效果。方法:选择医院80例符合慢性疲劳综合征的老年人为受试者。随机分为试验组(n=40)及安慰剂组(n=40),两组患者分别给予养生保健1号方及安慰剂干预45天。运用疲劳量表-14(Fatigue Scale 14,FS-14)评分判断患者用药前后疲劳等症状变化,同时对患者外周血T淋巴细胞亚群进行分析。结果:服药6周后,FS-14分析结果显示治疗组总有效率(35/40)87.5%,安慰剂组总有效率(5/40)12.5%,治疗组疗效优于安慰剂组(P<0.01)。治疗组NK细胞、CD3 T淋巴细胞检测较治疗前明显升高(P<0.05),与对照组差异显著(P<0.05),CD4/CD8治疗后轻度升高,但统计学无明显差异(P>0.05)。安慰剂组用药前后免疫各项指标变化不明显(P>0.05)。结论:养生保健1号方对治疗老年慢性疲劳综合征有效,对患者的免疫功能具有一定的调节作用。Objective : To evaluate the efficacy of Yangsheng Baojian 1 Formula, a compound traditional Chinese herbal medicine for treatment of chronic fatigue syndrome (CFS) in elderly patients. Methods:The study period was 45 days. 80 cases of CFS were divided randomly into the treatment group ( n =40) and control group ( n =40). The total score of Fatigue Scale - 14 (FS - 14) was used to evaluate the fatigue status of subjects and the change of the peripheral blood T cell subsets was measured before and after treatment. Results :According to the score changes of FS - 14 ,the complete effectiveness rates were 87.5% in treatment group and 12.5% in control group. The efficacy of the treatment group was superior to that of the control group ( P 〈 0. 01 ). The number of CD3 and NK increased obviously in treatment group and more than that of control group ( P 〈 O. 05 ). No adverse effects were found in the control group. Conclusion: Yangsheng Baojianl Formula is effective for the treatment of chronic fatigue syndrome in elderly patients and can enhance the function of cell immune.

关 键 词:养生保健1号方 慢性疲劳综合征 免疫功能 老年 

分 类 号:R285.6[医药卫生—中药学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象